I have gone down the NK rabbit hole! Could someone with the science background chime in on the results they are seeing with their immunotherapy treatment and how it compares (or doesn't) to leronlimab?

Not exactly sure of the differences when it comes to disease control rate and response rate. And some of the details seem qualified such as "no immune related SAEs".

Would this be considered a competitor to leronlimab or something that would be complementary?

Any insight would be appreciated!

Thanks for sharing ClosetInvestor...there seems to be a lot of new therapies out there!!